Literature DB >> 2863223

Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease.

R Paganelli, F Pallone, S Montano, S Le Moli, P M Matricardi, S Fais, P Paoluzi, R D'Amelio, F Aiuti.   

Abstract

We studied the class-specific antibody response to the cow's milk antigen beta-lactoglobulin (beta-LG) in sera from patients with ulcerative colitis and Crohn's disease. IgG and IgM to beta-LG were significantly higher in patients when compared to healthy non-atopic controls, whereas IgA values were similar, and specific IgE absent in all groups. No correlation between IgG- or IgM-containing immune complexes was found with the corresponding isotype of antibody to beta-LG; however, IgM complexes correlated with serum total IgM in ulcerative colitis. In these patients, IgG antibodies were higher in active cases, whereas IgM increased in patients without signs of disease activity. Antibody titers did not correlate with disease duration or administration of antiinflammatory drugs. This pattern of anti-beta-LG reactivity suggests that the presence of intestinal lesions may be revealed by the selective increase of some antibody isotypes to orally administered antigens. Enhanced mucosal permeability may be studied by this type of serological analysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863223     DOI: 10.1159/000233867

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  8 in total

1.  IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease.

Authors:  L Helgeland; C Tysk; G Järnerot; K Kett; E Lindberg; D Danielsson; S N Andersen; P Brandtzaeg
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

2.  Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease.

Authors:  E Lindberg; K E Magnusson; C Tysk; G Järnerot
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

4.  Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.

Authors:  H McKenzie; J Main; C R Pennington; D Parratt
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

5.  Determination of Anti-Anisakis Simplex Antibodies and Relationship with αβ and γδ Lymphocyte Subpopulations in Patients with Crohn's Disease.

Authors:  C Benet-Campos; C Cuéllar; C García-Ballesteros; V Zamora; R Gil-Borrás; I Catalán-Serra; F López-Chuliá; J C Andreu-Ballester
Journal:  Dig Dis Sci       Date:  2017-02-06       Impact factor: 3.199

6.  Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.

Authors:  L J Walker; M C Aldhous; H E Drummond; B R K Smith; E R Nimmo; I D R Arnott; J Satsangi
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 7.  Non-pulmonary allergic diseases and inflammatory bowel disease: a qualitative review.

Authors:  David S Kotlyar; Mili Shum; Jennifer Hsieh; Wojciech Blonski; David A Greenwald
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.

Authors:  J Main; H McKenzie; G R Yeaman; M A Kerr; D Robson; C R Pennington; D Parratt
Journal:  BMJ       Date:  1988-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.